Clinical Trial for Advanced Bile Duct Cancer
0 Bekeken
• 07/01/23
0
0
insluiten
administrator
abonnees
Learn about a phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma (bile duct cancer) with pembrolizumab and Sylatron (peginterferon alfa-2b): HCRN GI16-263. https://hoosiercancer.org/clin....ical-trials/trial/gi
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties